Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2024-12-06 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
马应龙关于获得药物临床试验批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 马应龙药业集团股份有限公司 regarding the receipt of a drug clinical trial approval notice from the National Medical Products Administration (国家药品监督管理局). It details the drug name, application details, approval conclusion, and risk warnings related to the clinical trial process. The document is short (1067 characters) and serves as an official announcement of regulatory approval for clinical trials, not a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-12-06 Chinese
马应龙2024年第一次临时股东大会法律意见书
Regulatory Filings
2024-12-02 Chinese
马应龙2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the company's first extraordinary general meeting of shareholders in 2024. It details the meeting date, attendance, voting results on director and supervisor elections, and legal witness statements confirming the validity of the meeting and voting process. There is no financial data or report content, only the official announcement of the voting results and meeting resolutions. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused solely on voting outcomes, not a full report or presentation.
2024-12-02 Chinese
马应龙2024年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2024 First Extraordinary General Meeting of Shareholders" of a company. It contains detailed information about the meeting agenda, including election proposals for new board members and supervisors, resignation reports of previous members, and their resumes. The content is focused on board and supervisory appointments and related governance matters. There is no financial data, earnings information, or audit content. The document is not a report itself but rather meeting materials for a shareholder meeting, specifically an extraordinary general meeting (EGM). According to the filing definitions, materials shared during a general meeting, including election proposals and related information, fall under AGM Information (AGM-R). The document length is about 4548 characters, which is consistent with detailed meeting materials rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2024-11-22 Chinese
马应龙关于控股股东部分股份解除质押及再质押的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the pledge and release of shares by the controlling shareholder of the company. It details the number of shares pledged, released, and re-pledged, along with the percentages of total shares and shareholder holdings. There is no financial statement, earnings data, or management discussion. The document is a formal disclosure about share pledge status, which fits the category of share issue or capital change announcements related to share pledges. It is not a full financial report, earnings release, or regulatory certification. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is short and focused on share pledge details, confirming it is not a report publication or regulatory filing.
2024-11-18 Chinese
马应龙第十一届董事会第十七次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the 17th meeting of the 11th Board of Directors of the company. It includes details about director resignations, nominations for new directors, and the scheduling of an upcoming extraordinary general meeting (EGM). The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is a board/management information announcement about changes in the board and upcoming shareholder meeting arrangements. The document is relatively short (1548 characters) and focuses on board decisions and nominations, fitting the category of Board/Management Information (MANG).
2024-11-15 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.